Total Holdings
26
Portfolio diversification across 26 positions
Assets Under Management
$391.59M
Total fund assets
Expense Ratio
0.35%
Annual management fee
Fund Issuer
VanEck
NASDAQ

Portfolio Allocations

Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.

Loading chart...

Top 26 Holdings by Portfolio Weight

View ticker symbols, company names, asset types, and allocation percentages for each position

Scroll to see more
BBH ETF holdings table showing rank, ticker symbol, company name, asset type, and portfolio weight percentage. The table displays the top 26 holdings sorted by portfolio weight. Click any ticker to view detailed stock or ETF analysis including price, financials, and performance metrics.
#SymbolNameTypeWeight
1
GILD logo
GILD
Gilead Sciences, Inc.Stock16.38%
2
AMGN logo
AMGN
Amgen Inc.Stock16.14%
3
VRTX logo
VRTX
Vertex Pharmaceuticals IncorporatedStock9.05%
4
REGN logo
REGN
Regeneron Pharmaceuticals, Inc.Stock7.42%
5
INSM logo
INSM
Insmed IncorporatedStock5.42%
6
NTRA logo
NTRA
Natera, IncStock5.16%
7
ARGX logo
ARGX
argenx NV ADRStock5.06%
8
IQV logo
IQV
IQVIA Holdings IncStock4.78%
9
B
BGNE
BeiGene, LtdStock3.89%
10
ALNY logo
ALNY
Alnylam Pharmaceuticals, IncStock3.85%
11
BIIB logo
BIIB
Biogen IncStock3.65%
12
ONC logo
ONC
BeOne Medicines AGStock3.51%
13
UTHR logo
UTHR
United Therapeutics CorporationStock3.49%
14
ILMN logo
ILMN
Illumina, IncStock2.90%
15
ICLR logo
ICLR
ICON Public Limited CompanyStock2.85%
16
INCY logo
INCY
Incyte CorporationStock2.37%
17
EXAS logo
EXAS
Exact Sciences CorporationStock2.24%
18
NBIX logo
NBIX
Neurocrine Biosciences, IncStock2.20%
19
MRNA logo
MRNA
Moderna, Inc.Stock2.20%
20
BNTX logo
BNTX
BioNTech SEStock2.04%
21
QGEN logo
QGEN
QIAGEN N.VStock1.66%
22
TECH logo
TECH
Bio-Techne CorporationStock1.63%
23
TEM logo
TEM
Tempus AI, Inc. Class A Common StockStock1.55%
24
RGEN logo
RGEN
Repligen CorporationStock1.39%
25
CRL logo
CRL
Charles River Laboratories International, Inc.Stock1.34%
26
BMRN logo
BMRN
BioMarin Pharmaceutical IncStock1.31%